Management of patients with oncogene-driven NSCLC: the shift towards personalized medicine - European Medical Journal

Management of patients with oncogene-driven NSCLC: the shift towards personalized medicine

Oncology

Prof. Solange Peters (Chair), Dr Anne-Marie Baird, Prof. Reinhard Büttner, and Dr Noemi Reguart, will discuss the importance of the implementation of biomarker testing in routine clinical practice and the current and future challenges associated with this practice.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Elevating the quality of healthcare globally

Elevating the quality of healthcare globally